SMTI (Sanara MedTech) Float Percentage Of Total Shares Outstanding: 58.05% (As of Jul. 04, 2026)


SMTI Sanara MedTech Inc SMTI
72 GF Score
Price $24.85
GF Value $45.63
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Sanara MedTech Float Percentage Of Total Shares Outstanding?

Sanara MedTech SMTI +2.48% 72 Float Percentage Of Total Shares Outstanding is 58.05% as of Jul. 04, 2026. GuruFocus rates SMTI with a GF Score™ of 72/100 and a GF Value™ of $45.63 (Possible Value Trap). The stock has 6 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sanara MedTech's float shares is 5.32 Mil. Sanara MedTech's total shares outstanding is 9.16 Mil. Sanara MedTech's float percentage of total shares outstanding is 58.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sanara MedTech's Insider Ownership is 23.51%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sanara MedTech's Institutional Ownership is 18.29%.

SMTI
72GF Score
Sanara MedTech Inc SMTI
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanara MedTech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sanara MedTech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.32/9.16
=58.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 58.05% mean?
Sanara MedTech (SMTI) has a Float Percentage Of Total Shares Outstanding of 58.05% as of Jul. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sanara MedTech and its competitors.
Is Sanara MedTech's Float Percentage Of Total Shares Outstanding too high?
Sanara MedTech's current Float Percentage Of Total Shares Outstanding is 58.05%. Overall, Sanara MedTech has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanara MedTech's Float Percentage Of Total Shares Outstanding compare to EMBC and KRMD?
Sanara MedTech's Float Percentage Of Total Shares Outstanding of 58.05% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Sanara MedTech and its competitors. Sanara MedTech's current Float Percentage Of Total Shares Outstanding is 58.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanara MedTech stock overvalued right now?
Based on GuruFocus' analysis, Sanara MedTech (SMTI) is currently considered Possible Value Trap. The stock's GF Value™ is $45.63, compared to a current price of $24.85 — trading 45.5% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 58.05%. Sanara MedTech's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Sanara MedTech (SMTI), the current Float Percentage Of Total Shares Outstanding is 58.05% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sanara MedTech (SMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Sanara MedTech stock appears to be undervalued. The current stock price of $24.85 is trading 45.5% below its estimated GF Value™ of $45.63. GuruFocus considers Sanara MedTech to be Possible Value Trap.

Key valuation signals for SMTI:

  • Float Percentage Of Total Shares Outstanding: 58.05%
  • GF Value™: $45.63 vs. price of $24.85 (45.5% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the SMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanara MedTech Business Description

Address 1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
72GF Score

Get the complete analysis for SMTI

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.85
Price
$45.63
GF Value